State-of-the-art medical care in one second.
  • Home
  • Oncology
  • Neurology
  • Clinical Trials Cloud
  • Imaging Core Lab Service
  • Software
  • Gallery
  • Contact Us
  • About LISIT

Cancer Imaging Biomarker

Computer assisted support of evaluation of the efficacy and safety of anti-cancer agents

LISIT performs the FDA approved treatment evaluation of the effectiveness and safety of cancer treatment, and then evaluates using a therapeutic effect dedicated software that conforms to the CE authentication and GCP-based CRF 21 part 11.

We will provide a tumor response evaluation solutions of in anti-cancer agents and cancer treatment (such as radiation therapy).

Evaluator can management the lesion from a variety of imaging modalities.

By clinical trial imaging management system in clinical pharmaceutical research, allows you to optimize the efficiency and quality of clinical trials and profits of the best compliant with the protocol.
画像
画像

mint Lesion.

mint Lesion developed by Mint Medical GmbH is the best software for cancer lesion management bring together the wisdom of German Cancer Research Center: DKFZ.
We LISIT arranges the Japanese style of the structured report and analysis exported XML of criteria which is WHO, RECIST, CHOI, or REICIST 1.1 modified ir-RC of immunotherapy etc.

mint Lesion is a Class II approved software European CE, it complys with the CRF21 part 11 for worldwide complicated clinical research, clinical trials and FDA corresponding to the international collaborative trials.

Clinical trial manager, measured from the DICOM editing, judgment result report, to electronic signature, you can automate streamline all processes.

Key Feature of Oncologic Imaging Service

  • RECIST 1.0, RECIST 1.1, WHO, Choi, irRC, Cheson, mRECIST HCC, EASL, RANO, PERSIST 1.0, RECIST 1.1 modified irRC etc
  • Improve efficiency and quality of your tumor response evaluations
  • Various quantitative parameters support your assessment, including tumor density (HU) analysis, histogram analysis, and semi-automated tumor volumetry
  • CE-compliant and FDA-510k cleared medical product for use in patient care (class II b)Thin-Client Usage: Install once, have availability everywhere on all reading workstations
  • Seamless integration into your IT (RIS, PACS, EMR)Automated generation of structured reports
  • Automated response assessment according to criteria, like e.g. ‘partial response’
  • Following guidelines of FDA GMP, QSR, GCP, HIPAA, and Part 11 Electronic Records Standards to meet Imaging Core Lab (ICL) standards
  • Dedicated modules for Independent Review Committees (IRC) including user roles for IRC Reviewers, IRC Imaging-CRAs, IRC Project Managers, IRC Adjudicators, and more
  • Seamless integration into your existing IT environment by ThinClient usage, and by compliance with recognized standards for communication of image and result data
  • Interfaces to established Clinical Trial Management and EDC systems
  • Automated generation of eCRFs
Contact us for MOre Information

WatchinGGO
(Characteristics Analyzer for Lung Cancer Nodule and mixed GGOs)

画像
Selection of useful imaging biomarkers from international paper survey, is a software that specializes in tumor analysis of lung cancer that is designed to be able to calculate any quantity analysis values for the quantitative index of lung cancer.

Three-dimensional region GGN-mass index and histogram feature amount of volume obtained from such as by extraction, fractal analysis, such as a tumor center radial profiles of various quantitative index can be calculated.

Brochure is here.



ご利用のブラウザでは、このドキュメントの表示はサポートされていません。ドキュメントをダウンロードするには、こちらをクリックしてください。
のシステムを使用 カスタマイズできるテンプレートで世界唯一のウェブサイトを作成できます。
  • Home
  • Oncology
  • Neurology
  • Clinical Trials Cloud
  • Imaging Core Lab Service
  • Software
  • Gallery
  • Contact Us
  • About LISIT